Lymphedema, Low-grade Inflammation and the Vasculature in Turner Syndrome
Launched by UNIVERSITY OF AARHUS · Mar 15, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how Turner Syndrome (TS) affects the cardiovascular and lymphatic systems in women. Researchers will look at 100 women with TS who have already been part of previous studies over the last 19 years. They will also include healthy women of similar ages as a comparison group. The goal is to explore how the unique features of TS might lead to heart and lymphatic issues and to find ways to help prevent or treat serious health problems related to these systems.
To be eligible for this study, participants must have a confirmed diagnosis of Turner Syndrome. Women who are pregnant or have certain medical issues that would prevent them from having an MRI (a type of detailed imaging scan) cannot participate. Those who join the trial can expect to undergo a series of tests to assess their heart and lymphatic health. This research is important because it aims to improve our understanding of TS and hopefully lead to better care for women living with this condition.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Turner Syndrome
- Exclusion Criteria:
- • pregnancy
- • contraindications for MRI
About University Of Aarhus
The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarhus N, , Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported